Metropolitan Life Insurance Company (MetLife)’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,749
Closed -$35.5K 1168
2024
Q1
$35.5K Sell
5,749
-1,109
-16% -$7.47K ﹤0.01% 1576
2023
Q4
$53.7K Hold
6,858
﹤0.01% 1412
2023
Q3
$47.1K Buy
6,858
+992
+17% +$8.04K ﹤0.01% 1432
2023
Q2
$53.6K Buy
5,866
+1,709
+41% +$14.2K ﹤0.01% 1377
2023
Q1
$30.9K Sell
4,157
-772
-16% -$4.28K ﹤0.01% 1664
2022
Q4
$24.3K Hold
4,929
﹤0.01% 1904
2022
Q3
$32.6K Hold
4,929
﹤0.01% 1745
2022
Q2
$27.4K Hold
4,929
﹤0.01% 1879
2022
Q1
$49.8K Sell
4,929
-8,402
-63% -$73.7K ﹤0.01% 1593
2021
Q4
$127K Hold
13,331
﹤0.01% 2335
2021
Q3
$193K Buy
+13,331
New +$257K ﹤0.01% 2102

Other funds holding LFST

Metropolitan Life Insurance Company (MetLife)'s LFST Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Lifestance Health (LFST) in Q2 2024, closing a stake of 5,749 shares — an estimated $35.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LFST in Q3 2021 and held it in 11 quarters. The position peaked at $193K in Q3 2021. 133 funds tracked by Wall St. Rank hold LFST as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Lifestance Health position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,749 Lifestance Health shares in Q2 2024, an estimated $35.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Lifestance Health in Q3 2021 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Lifestance Health position peaked at $193K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.